The Union is pleased to announce a series of Union World Conference virtual Post-Graduate Courses and Workshops. These are free to attend.
Deciding where to place GeneXpert for TB testing is constrained by several factors. GeneXpert platform multiplexing for SARS-CoV-2 testing presents even further considerations for where to expand Xpert machines and cartridge distribution, and how to balance TB and COVID-19 testing priorities. The workshop will be conducted through an online game-like environment, which builds on KIT’s existing MATCH diagnostic optimization game. In the game, the government of fictitious country Iwalamba has given a proportion of TB facility laboratories the mandate to use their Xpert platforms for COVID-19 testing in addition to the routine TB and HIV testing workload.
Workshop participants will face four new challenges in the updated game, revolving around optimizing TB testing availability and maximizing 20-kilometer catchment population access to TB and COVID-19 Xpert-based diagnostic services, while minimizing the negative impacts of diverting TB resources to meet COVID-19 testing needs.
This session aims to discuss lessons learnt and further strengthen integration between tuberculosis (TB) and HIV programmes; as well as increase diverse stakeholders’ involvement in the multi-sectoral accountability framework to accelerate progress to end TB. The session will focus on the key populations, particularly people who use drugs and transgender people. This workshop brings attention to the previously neglected topics of community responses, people who use drugs and transgender communities. It gives space to civil society and community leaders to share their data, experiences and lessons learnt. This session aims to analyse different models of community systems across high burden countries.
Following the World Health Organization’s (WHO) 2017 recommendations on Xpert MTB/RIF Ultra (Ultra), several national Tuberculosis (TB) Programmes have transitioned, with several million Ultra tests being performed globally. Interpretation of Ultra results is the same as for the previous cartridge version except for ‘MTB trace detected’ (‘trace’), the lowest bacillary TB burden detected.
This workshop will explore implementation approaches with ‘trace’’ management, and will address the challenges encountered in countries, highlighting the new cartridge’s impact on treatment and management of TB, including the management of drug resistance and co-infected HIV patients, and present existing approaches and strategies to overcome these challenges.
Speakers will also set the scene for discussions on how countries use and adapt algorithms for an effective integrated, person-centred approach at the core of care and support to all TB/HIV co-infected people.
Following that, participants will be asked to join one of the two break-out rooms:
1) Case studies on Ultra results management with clinicians
2) Exercises on Modelling Tool (Local feasibility and Impact modelling Tool- FIND)
Treatment of TB is evolving rapidly with many novel and repurposed drugs offering new hope to patients, especially those with MDR-TB. What can TB programmes and researchers do to ensure that they are addressing the most important questions and generating data sufficient to address them in the most timely manner? How can regulators and policy-makers make the best use of these randomized and observational data? This workshop is aimed at producers and consumers of research evidence and guidance in MDR-TB with the aim of fostering a deeper understanding of the issues raised by the different kinds of data and methods available to guideline panels in this complex and fast-moving area. Workshop attendees will strengthen their knowledge and appreciation of the most recent advances in design and analysis of observational cohorts and clinical trials and the implications of these in policy-making and guideline development.
The recent COVID-19 pandemic has highlighted the importance of airborne infection prevention and control (IPC) in healthcare and congregate settings. There continues to be a lack of knowledge and skills needed to develop effective and sustainable programmes. This workshop will reinforce the basics of airborne IPC (administrative controls, environmental controls, and personal protective equipment).
In this Post-Graduate Course speakers will introduce participants to the basic principles and components of the ECHO model and review examples of the adaptation of the model in a variety of TB epidemic contexts in both high and low burden settings. We will also review a robust evaluation protocol and plan.
The objective of the workshop is to familiarize the audience with the Target Product Profiles (TPPs) for future Tuberculosis Preventive Treatment (TPT). The workshop will describe the context in which the TPPs were developed, discuss the methodology used to select and prioritize key attributes, and present a review of the evidence. The workshop requires interactive participation of participants.